Related Experiment Video
Updated: Jul 6, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
Explanatory models of epilepsy: key deterrents to seeking biomedical care and effective epilepsy management in Uganda
Mayanja M Kajumba1, Angelina Kakooza-Mwesige2, Mark Kaddumukasa3
1Department of Mental Health and Community Psychology, Makerere University, Kampala, Uganda.
Background:
The Sub-Saharan region has one of the largest populations with misconceptions about the etiology, manifestation, and management of epilepsy. Consequently, the majority of people living with epilepsy (PWE) receive unorthodox interventions that contribute to persistent uncontrolled seizures and poor quality of life. This study aimed to explore the prevailing explanatory models of epilepsy and their role in determining health-seeking behavior.
Methods:
We utilized a qualitative, phenomenological design, with a sample of 128 participants, comprising of 19 Adolescents with Epilepsy (AWE) and 109 key-informants, including caregivers, healthcare workers, teachers, traditional and faith healers, and community leaders.
Results:
Both PWE and community members held various beliefs about epilepsy, with a predominant pluralistic explanatory model characterized by a combination of biological, social, and supernatural assumptions. There was a high preference for supernatural remedies from traditional and/or faith healers, which seemed to be a major barrier to the uptake and adherence to biomedical care.
Conclusion:
The prevailing explanatory models might account for the observation that the PWE, including those on anti-seizure medication, often engage in non-allopathic care that can impact reaching or maintaining biomedical treatment. Effective epilepsy management requires a multi-pronged approach involving the utilization of contextually tailored epilepsy literacy programs and collaboration with traditional and faith healers to facilitate linkage to biomedical care.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures l: Introduction
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy

